Welcome to Markets Desk, your midday read on what's moving and why.
The Dow is swinging hard again, marking its third thousand-point move in just four days. The catalyst this time is a familiar one: Nvidia. The chipmaker opened an internal probe following scandal around CEO Jensen Huang, sending the stock lower even as broader indexes managed a rally. One strategist put it plainly — Washington has shifted from tailwind to headwind almost overnight, and until that uncertainty clears, expect the volatility to stay.
On the Nvidia story specifically, there is a counterintuitive angle worth watching. The so-called Jensen-Gate scandal may actually tighten chip supply to China, which could redirect more AI hardware toward domestic cloud giants. If Beijing faces deeper restrictions on Megaspeed and related suppliers, American hyperscalers could find themselves with better access to the chips they've been competing for. Demand for AI infrastructure hasn't moved — only the supply chain politics have.
Elsewhere, a quieter but sobering story out of biotech. Acumen Pharmaceuticals is approaching Chapter eleven after its Alzheimer's candidate failed in trials. The company had invested years and millions chasing a drug that could have reshaped medicine. It's a reminder that for every blockbuster, the industry absorbs losses most investors never fully price in.
That's the tape. Markets Desk, signing off the floor.
